‘Attract highly qualified persons, offer sensible terms and conditions’
Affordability, availability and access to healthcare requires: Indian regulator to approve in a timely manner generics and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘The Indian Government needs to implement favourable policies that enhance innovation and…
It is said that the wealth of a nation depends on the health of its citizens. But ironically, the healthcare and pharmaceutical…
‘The new Government has an opportunity for creating a system of universal healthcare that can…
As India counts down to the start of the 2014 general elections, there is hope all around that these elections will usher in a…
‘The first thing that should be done is to accord healthcare infrastructure status’
Affordability, availability and access are becoming increasingly important particularly in the context of healthcare. The pharma…
‘There should be a separate agency exclusively for drug research on the lines of DBT’
Intellectual Property Rights (IPR) in India enjoy a very good status altough it has been criticised a lot by the US officials. The…
‘Stringent regulatory measures are required to reign in inessential medicines’
The next Government in Delhi must ensure the following in order to realise the goals of access to affordable medicines in India.…
Healthcare A Poli-Trickal Issue
Indian political parties are busy wooing voters with myriad promises for the General Elections 2014. Yet healthcare, a vital…
Piramal to acquire 20 per cent equity stake in Shriram Capital
Piramal had invested Rs 1,636 crore in May last year to acquire ~9.9 per cent equity in Shriram Transport Finance Company
’New product development and launch remains a very critical area for pharma companies’
In its latest report, Accenture outlines how innovation driven high performers are changing the landscape in the pharma industry.…
Sun Pharma to acquire Ranbaxy in $4-billion landmark transaction
To create world’s fifth largest specialty generic pharma company